CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CORONA Remedies Limited has informed the exchanges that its trading window for dealing in company securities will remain closed from January 01, 2026, until 48 hours after the declaration of its unaudited financial results for the third quarter and nine months ending December 31, 2025. This closure is being implemented as per SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal insider trading code. During this period, designated persons and insiders are restricted from trading in the company's shares. The date of the board meeting to consider and approve the Q3 FY26 results will be communicated to the exchanges separately.
This is a routine regulatory compliance filing and does not directly affect shareholders. It signals that the company's Q3 FY26 earnings announcement is approaching, and investors should watch for the upcoming board meeting date and results declaration, which could be a near-term catalyst for the stock.